Non-Fiction Books:

Analytical Similarity Assessment in Biosimilar Product Development

Format

Hardback

Customer rating

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Share this product

Analytical Similarity Assessment in Biosimilar Product Development by Shein-Chung Chow
Save $161.00
$248.99 was $409.99
or 4 payments of $62.25 with Learn more
Out of stock

The item is currently out of stock with all our suppliers. Order this item and Mighty Ape will place a backorder and it will ship as soon as it becomes available. The delivery time shown is an estimate based on past averages and subject to change.

Usually ships within 6-8 weeks

Availability

Delivering to:

Estimated arrival:

  • Approx. 3-16 October using standard courier delivery

Description

This book focuses on analytical similarity assessment in biosimilar product development following the FDA's recommended stepwise approach for obtaining totality-of-the-evidence for approval of biosimilar products. It covers concepts such as the tiered approach for assessment of similarity of critical quality attributes in the manufacturing process of biosimilar products, models/methods like the statistical model for classification of critical quality attributes, equivalence tests for critical quality attributes in Tier 1 and the corresponding sample size requirements, current issues, and recent developments in analytical similarity assessment.

Author Biography

Author Shein-Chung Chow, Ph.D, is currently an Associate Director at Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Prior to joining FDA, Dr. Chow was a Professor at Duke University School of Medicine, Durham, NC. He was also a special government employee (SGE) appointed by the FDA as an Advisory Committee member and statistical advisor to the FDA. Prior to that, Dr. Chow also held various positions in the pharmaceutical industry such as Vice President at Millennium, Cambridge, MA, Executive Director at Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers Squibb, Plainsboro, NJ. Dr. Chow is the Editor-in-Chief of the Journal of Biopharmaceutical Statistics and the Editor-in-Chief of the Biostatistics Book Series at Chapman and Hall/CRC Press, Taylor & Francis Group. He was elected Fellow of the American Statistical Association and an elected member of the ISI (International Statistical Institute). Dr. Chow is the author or co-author of over 300 methodology papers and 29 books including Designs and Analysis of Bioavailability and Bioequivalence Studies, Sample Size Calculations in Clinical Research, Adaptive Design Methods in Clinical Trials, Translational Medicine, Design and Analysis of Clinical Trials, and Quantitative Methods for Traditional Chinese Medicine Development.
Release date Australia
August 8th, 2018
Country of Publication
United Kingdom
Illustrations
70 Tables, black and white
Imprint
CRC Press
Pages
340
ISBN-13
9781138307339
Product ID
28247451

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

  • If you think we've made a mistake or omitted details, please send us your feedback. Send Feedback
  • If you have a question or problem with this product, visit our Help section. Get Help
  • Seen a lower price for this product elsewhere? We'll do our best to beat it. Request a better price
Filed under...